These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1125626)

  • 1. Anticoagulant resistance: an unusual case.
    Barnett DB; Hancock BW
    Br Med J; 1975 Mar; 1(5958):608-9. PubMed ID: 1125626
    [No Abstract]   [Full Text] [Related]  

  • 2. Some aspects of the pharmacology of oral anticoagulants.
    Coon WW; Willis PW
    Clin Pharmacol Ther; 1970; 11(3):312-36. PubMed ID: 4192279
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Normalized Ratio (INR) increase in patients taking oral anticoagulant therapy (OAT) and using sildenafil (Viagra).
    Fernández MA; Romá E
    Haematologica; 2003 Dec; 88(12):ELT34. PubMed ID: 14688013
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of nitro-- derivatives of warfarin on blood coagulation].
    Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA
    Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tramadol and oral anticoagulants: interaction or confounding factors?].
    Chiffoleau A; Veyrac G; Dudouet D; Miremont G; Merle L; David-Laroche M; Bourin M; Jolliet P
    Therapie; 2003; 58(5):471-4. PubMed ID: 14682201
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acquired warfarin resistance in a patient with mechanical heart valve].
    Gøtze JP; Thorsen S; Haunsø S
    Ugeskr Laeger; 2001 Dec; 163(50):7075-6. PubMed ID: 11794043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.
    BAUGH CW
    Can Med Assoc J; 1965 Jan; 92(3):116-20. PubMed ID: 14232183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
    Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
    Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADMINISTRATION AND CONTROL OF ANTICOAGULANT TREATMENT.
    POLLER L
    Manch Med Gaz; 1964; 43():8-11. PubMed ID: 14125255
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants.
    Schwarz UI; Stein CM
    Clin Pharmacol Ther; 2006 Jul; 80(1):7-12. PubMed ID: 16815312
    [No Abstract]   [Full Text] [Related]  

  • 12. Cimetidine: interaction with oral anticoagulants in man.
    Serlin MJ; Sibeon RG; Mossman S; Breckenridge AM; Williams JR; Atwood JL; Willoughby JM
    Lancet; 1979 Aug; 2(8138):317-9. PubMed ID: 89387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial.
    Laporte S; Quenet S; Buchmüller-Cordier A; Reynaud J; Tardy-Poncet B; Thirion C; Decousus H; Mismetti P
    Thromb Haemost; 2003 Mar; 89(3):458-67. PubMed ID: 12624628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of thromboelastography in evaluating other anticoagulant agents: warfarin and heparin-dihydroergotamine.
    Traverso CI; Arcelus JI; Caprini JA
    Semin Thromb Hemost; 1995; 21 Suppl 4():59-62. PubMed ID: 8747690
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of kinetic parameters for prothrombin complex activity during initiation of anticoagulation.
    Kuranari M; Hara M; Saikawa T; Kodama Y; Matsuo H; Sakata T; Takeyama M
    J Clin Pharm Ther; 1997; 22(5-6):347-51. PubMed ID: 19160719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of furosemide and bumetanide on warfarin metabolism and anticoagulant response.
    Nilsson CM; Horton ES; Robinson DS
    J Clin Pharmacol; 1978; 18(2-3):91-4. PubMed ID: 624779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 18. The second reported kindred with hereditary resistance to oral anticoagulant drugs.
    O'Reilly RA
    N Engl J Med; 1970 Jun; 282(26):1448-51. PubMed ID: 4192578
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.
    Yacobi A; Wingard LB; Levy G
    J Pharm Sci; 1974 Jun; 63(6):868-72. PubMed ID: 4851098
    [No Abstract]   [Full Text] [Related]  

  • 20. Warfarin: effects on anticoagulant, hematologic, and blood enzyme values in normal ponies.
    Scott EA; Sandler GA; Byars TD
    Am J Vet Res; 1979 Jan; 40(1):142-6. PubMed ID: 453677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.